R&D

New drug Research Laboratory


Frombio¡¯s New drug research laboratory is researching and developing new drug and incrementally modified drug centering around chemical synthetic drug and platform technology for drug delivery.

For health of humanity in the future, development of first-in-class drug

New drug research laboratory, to be in charge of health of humanity is studying constantly and composing pipe line for development of first-in-class drug and differentiated platform.

Development of differentiated new drug and securing competitiveness using platform technology for new drug

To find out and solve origin cause of varieties disease of humanity like inflammation disease, autoimmune disease, allergic disease and cancer etc we establish network with lots of research institute and develop medicine using a state of the art research facilities.

we will take the lead in securing competitiveness as development of new drug and platform technology of new drug for health in the future.

Development of
first-in-class drug

Development of
medicine for autoimmune disease

Development of
platform technology for new drug

Ongoing Project


FB-P001
Item
  • Research
  • Preclinical
  • Phase1
  • Phase2
  • Phase3
solid cancer
Fibrosis
lung disease
autoimmune disease
FB-VP101
Item
  • Research
  • Preclinical
  • Phase1
  • Phase2
  • Phase3
Drug delivery system
FB-VP201
Item
  • Research
  • Preclinical
  • Phase1
  • Phase2
  • Phase3
platform technology for new drug

Ongoing Project


FB-P001
Item | solid cancer
  • Research
  • Preclinical
  • Phase1
  • Phase2
  • Phase3
Item | Fibrosis
  • Research
  • Preclinical
  • Phase1
  • Phase2
  • Phase3
Item | lung disease
  • Research
  • Preclinical
  • Phase1
  • Phase2
  • Phase3
Item | autoimmune disease
  • Research
  • Preclinical
  • Phase1
  • Phase2
  • Phase3
FB-VP101
Item | Drug delivery system
  • Research
  • Preclinical
  • Phase1
  • Phase2
  • Phase3
FB-VP201
Item | platform technology for new drug
  • Research
  • Preclinical
  • Phase1
  • Phase2
  • Phase3